The increased risk for Wilms tumor in patients with WAGR syndrome is caused by a haploinsufficiency of WT1 (OMIM: 607102); it has been suggested that LMO2 gene haploinsufficiency contributes to a further increase in this risk, based on a genotype–phenotype correlation analysis [1]. This evidence concerns the gene LMO2 and WAGR syndrome.